Liu P-Y, Zhang Y-Y, Lu Y, Long J-R, Shen H, Zhao Lan-J, Xu F-H, Xiao P, Xiong D-H, Liu Y-J, Recker R R, Deng H-W
Osteoporosis Research Center, Creighton University, Omaha, NE 68131, USA.
J Med Genet. 2005 Mar;42(3):221-7. doi: 10.1136/jmg.2004.024752.
The haplotype based association method offers a powerful approach to complex disease gene mapping. In this method, a few common haplotypes that account for the vast majority of chromosomes in the populations are usually examined for association with disease phenotypes. This brings us to a critical question of whether rare haplotypes play an important role in influencing disease susceptibility and thus should not be ignored in the design and execution of association studies.
To address this question we surveyed, in a large sample of 1873 white subjects, six candidate genes for osteoporosis (a common late onset bone disorder), which had 29 SNPs, an average marker density of 13 kb, and covered a total of 377 kb of the DNA sequence.
Our empirical data demonstrated that two rare haplotypes of the parathyroid hormone (PTH)/PTH related peptide receptor type 1 and vitamin D receptor genes (PTHR1 and VDR) with frequencies of 1.1% and 2.9%, respectively, had significant effects on osteoporosis phenotypes (p = 4.2 x 10(-6) and p = 1.6 x 10(-4), respectively). Large phenotypic differences (4.0 approximately 5.0%) were observed between carriers of these rare haplotypes and non-carriers. Carriers of the two rare haplotypes showed quantitatively continuous variation in the population and were derived from a wide spectrum rather than from one extreme tail of the population phenotype distribution.
These findings indicate that rare haplotypes/variants are important for disease susceptibility and cannot be ignored in genetics studies of complex diseases. The study has profound implications for association studies and applications of the HapMap project.
基于单倍型的关联方法为复杂疾病基因定位提供了一种强大的途径。在这种方法中,通常会检查少数几种在人群中占绝大多数染色体的常见单倍型与疾病表型的关联。这就引出了一个关键问题,即罕见单倍型在影响疾病易感性方面是否发挥重要作用,因此在关联研究的设计和实施中不应被忽视。
为了解决这个问题,我们在1873名白人受试者的大样本中,对六个骨质疏松症(一种常见的晚发性骨疾病)候选基因进行了调查,这些基因有29个单核苷酸多态性(SNP),平均标记密度为13千碱基对(kb),共覆盖377 kb的DNA序列。
我们的经验数据表明,甲状旁腺激素(PTH)/甲状旁腺激素相关肽受体1型和维生素D受体基因(PTHR1和VDR)的两种罕见单倍型,频率分别为1.1%和2.9%,对骨质疏松症表型有显著影响(分别为p = 4.2×10⁻⁶和p = 1.6×10⁻⁴)。在这些罕见单倍型的携带者和非携带者之间观察到了较大的表型差异(4.0%至5.0%左右)。这两种罕见单倍型的携带者在人群中表现出定量的连续变异,并且来自广泛的范围,而不是人群表型分布的一个极端尾部。
这些发现表明,罕见单倍型/变异体对疾病易感性很重要,在复杂疾病的遗传学研究中不能被忽视。该研究对关联研究和国际人类基因组单体型图计划(HapMap)项目的应用具有深远意义。